Table 2.

Time course of SCr and proteinuria after rituximab treatmenta

PatientBaselineMonth 1Month 6Month 12Last VisitFollow-up (mo)IS Treatmentb
BP (mm/Hg)SCr (mg/dl)Prot (g/24 h)SCr (mg/dl)Prot (g/24 h)SCr (mg/dl)Prot (g/24 h)SCr (mg/dl)Prot (g/24 h)SCr (mg/dl)Prot (g/24 h)
1110/761.2161.914.01.816.01.4015.01.415.012TAC (4) MMF (4)
292/640.916.50.821.00.914.20.815.81.115.812CSA (3) MMF (3)
3140/781.49.41.411.31.311.31.19.81.29.814TAC (6)
4110/620.912.01.114.01.812.02.610.66.514.018CSA (3) MMF (3)
5122/850.99.80.810.51.112.21.411.61.913.324CSA (5)
6114/642.312.72.55.72.510.02.713.03.29.024ST (12) MMF (2)
7124/721.712.91.66.31.58.11.43.21.43.212ST (10) TAC (8) MMF (8)
8110/601.923.01.67.81.17.51.03.91.03.915CSA (4) MMF (12)
  • a IS, immunosuppressive; Prot, proteinuria; SCr, serum creatinine.

  • b Duration (in months) of IS treatment after rituximab appears in parentheses after every IS drug.